Herbal extract products and methods

Abstract

The present invention relates to a product for topical administration in particular, a product for use in the treatment of eczema and psoriasis and other related conditions.

What is claimed is: 
     
         1 . A therapeutic product adapted for topical administration, the product including a mixture of herbal extracts comprising  Melia Azadirachta  extract present in an amount of 0.01% to 2.5% w/w,  Withania Somnifera  extract present in an amount of 0.01% to 2.5% w/w,  Aloe Barbadensis  extract present in an amount of 0.01% to 20% w/w, or a combination thereof. 
     
     
         2 . The therapeutic product of  claim 1 , wherein the therapeutic product further comprises:
 at least one moisturising agent selected from the group consisting of saccharide isomerate, sodium hyaluronate, phospholipids, biosaccharide gum-1, and glycyrrhetinic acid;   at least one repairing agent selected from the group consisting of allantoin, spent grain wax,  argania spinosa  kernel oil,  butyrospermum parkii  (shea butter) extract, and sodium carboxymethyl beta-glucan; and   at least one purifying agent selected from the group consisting of 4-terpineol and piroctone olamine.   
     
     
         3 . The therapeutic product of  claim 2 , wherein the at least one moisturising agent is 0.25% to 6% w/w of saccharide isomerate, 0.005% to 0.5% w/w of sodium hyaluronate, 0.005% to 1% w/w of phospholipids, 0.005% to 0.8% w/w of biosaccharide gum-1, or 0.001% to 1% w/w of glycyrrhetinic acid;
 wherein the at least one repairing agent is 0.1% to 5% w/w of allantoin, 0.2% to 10% w/w of spent grain wax, 0.1% to 20% w/w of  argania spinosa  kernel oil, 0.1% to 20% w/w of  butyrospermum parkii  (shea butter) extract, or 0.005% or 1% w/w of sodium carboxymethyl beta-glucan; and   wherein the at least one purifying agent is 0.05%to 5% w/w of 4-terpineol or 0.01% to 0.5% w/w of piroctone olamine.   
     
     
         4 . The therapeutic product of  claim 3 , which comprises 2.75% w/w of saccharide isomerate, 0.1% w/w of sodium hyaluronate, 0.07% w/w of phospholipids, 0.055% w/w of biosaccharide gum-1, 0.03% w/w of glycyrrhetinic acid; 2.0% w/w of allantoin, 2.0% w/w of spent grain wax, 1.75% w/w of  argania spinosa  kernel oil, 1.25% w/w of  butyrospermum parkii  (shea butter) extract, 0.1% w/w of sodium carboxymethyl beta-glucan; 1% w/w of 4-terpineol, and 0.5% w/w of piroctone olamine. 
     
     
         5 . The therapeutic product of  claim 1 , wherein the therapeutic product further comprises a moisturising agent that includes 0.25% to 6% w/w of saccharide isomerate, 0.005% to 0.5% w/w of sodium hyaluronate, 0.005% to 1% w/w of phospholipids, 0.005% to 0.8% w/w of biosaccharide gum-1, and 0.001% to 1% w/w of glycyrrhetinic acid;
 a repairing agent that includes 0.1% to 5% w/w of allantoin, 0.2% to 10% w/w of spent grain wax, 0.1% to 20% w/w of  argania spinosa  kernel oil, 0.1% to 20% w/w of  butyrospermum parkii  (shea butter) extract, and 0.005% or 1% w/w of sodium carboxymethyl beta-glucan; or   a purifying agent that includes 0.05%to 5% w/w of 4-terpineol and 0.01% to 0.5% w/w of piroctone olamine.   
     
     
         6 . The therapeutic product of  claim 1 , wherein the  Melia Azadirachta  extract comprises  Melia Azadirachta  leaf extract. 
     
     
         7 . The therapeutic product of  claim 1 , wherein the  Withania Somnifera  extract comprises  Withania Somnifera  root extract. 
     
     
         8 . The therapeutic product of  claim 1 , wherein the  Aloe Barbadensis  extract comprises  Aloe Barbadensis  leaf juice. 
     
     
         9 . The therapeutic product of  claim 1 , wherein the herbal mixture comprises  Melia Azadirachta  leaf extract,  Withania Somnifera  root extract, and  Aloe Barbadensis  leaf juice. 
     
     
         10 . The therapeutic product of  claim 2 , wherein the product is formulated as an ointment or a cream. 
     
     
         11 . An eczema-treating product comprising the therapeutic product of  claim 10 . 
     
     
         12 . A psoriasis-treating product comprising the therapeutic product of  claim 10 . 
     
     
         13 . The therapeutic product of  claim 1 , wherein the  Melia Azadirachta  extract is present in an amount of 0.5% w/w. 
     
     
         14 . The therapeutic product of  claim 1 , wherein the  Withania Somnifera  extract is present in an amount of 0.45% w/w. 
     
     
         15 . The therapeutic product of  claim 1 , wherein the  Aloe Barbadensis  extract is present in an amount of 0.02% w/w. 
     
     
         16 . A method for treating at least one skin condition, which comprises administering a therapeutically effective amount of a pharmaceutical composition including an herbal extract comprising  Melia Azadirachta  present in an amount of 0.01% to 2.5% w/w,  Withania Somnifera  extract present in an amount of 0.01% to 2.5% w/w,  Aloe Barbadensis  extract present in an amount of 0.01% to 20% w/w, or a combination thereof, to facilitate treatment of the at least one skin condition. 
     
     
         17 . The method of  claim 16 , wherein the skin condition is eczema. 
     
     
         18 . The method of  claim 16 , wherein the skin condition is psoriasis. 
     
     
         19 . The method of  claim 18 , wherein the pharmaceutical composition comprises at least one moisturising agent selected from the group consisting of saccharide isomerate, sodium hyaluronate, phospholipids, biosaccharide gum-1, and glycyrrhetinic acid;
 at least one repairing agent selected from the group consisting of allantoin, spent grain wax,  argania spinosa  kernel oil,  butyrospermum parkii  (shea butter) extract, and sodium carboxymethyl beta-glucan; and   at least one purifying agent selected from the group consisting of 4-terpineol and piroctone olamine.   
     
     
         20 . The method of  claim 19 , wherein the pharmaceutical composition comprises saccharide isomerate, sodium hyaluronate, phospholipids, biosaccharide gum-1, glycyrrhetinic acid, allantoin, spent grain wax,  argania spinosa  kernel oil,  butyrospermum parkii  (shea butter) extract, sodium carboxymethyl beta-glucan, 4-terpineol, and piroctone olamine. 
     
     
         21 . The method of  claim 19 , wherein the at least one moisturising agent is 0.25% to 6% w/w of saccharide isomerate, 0.005% to 0.5% w/w of sodium hyaluronate, 0.005% to 1% w/w of phospholipids, 0.005% to 0.8% w/w of biosaccharide gum-1, or 0.001% to 1% w/w of glycyrrhetinic acid;
 wherein the at least one repairing agent is 0.1% to 5% w/w of allantoin, 0.2% to 10% w/w of spent grain wax, 0.1% to 20% w/w of  argania spinosa  kernel oil, 0.1% to 20% w/w of  butyrospermum parkii  (shea butter) extract, or 0.005% or 1% w/w of sodium carboxymethyl beta-glucan; and   wherein the at least one purifying agent is 0.05%to 5% w/w of 4-terpineol or 0.01% to 0.5% w/w of piroctone olamine.